Common death receptor 4 (DR4) polymorphisms do not predispose to ovarian cancer

Peter Horak1, Dietmar Pils, Max Roessler

  • 1Clinical Division of Oncology, Department of Medicine I, Medical University and University Hospital, Währinger Gürtel 18-20, A-1090 Vienna, Austria.

Abstract